Tae-Hoon Kim1, Youe Ree Kim2,3, Chang-Won Jeong1, Chungsub Lee1, SiHyeong Noh1, Ji Eon Kim1, Young Hwan Lee2,3, and Kwon-Ha Yoon2,3
1Medical Convergence Research Center, Wonkwang University, Iksan, Korea, Republic of, 2Radiology, Wonkwang University School of Medicine, Iksan, Korea, Republic of, 3Radiology, Wonkwang University Hospital, Iksan, Korea, Republic of
Synopsis
The assessment of liver surface nodularity (LSN) is
emerging importance to diagnose hepatic fibrotic changes in clinical. The
imaging techniques MRI and CT are gold-standard methods to estimate LSN scores.
However, in clinical practice, the manual LSN assessment of whole liver is
time-consuming. Therefore, it is powerful for assessing LSN score from a single
slice image instead of whole liver images. This study compared the regional
variation of LSN score for assessing fibrotic changes on a single liver MR
image in chronic liver disease (CLD).
Introduction
To
diagnose and stage hepatic fibrotic and cirrhotic changes within the liver, the
assessment of liver surface nodularity (LSN) is emerging importance in clinical.
The imaging techniques MRI and CT are gold-standard methods to estimate LSN
scores. The LSN can be measured on routine liver CT and MR images using
post-processing software to generate a LSN score. However, in clinical
practice, the manual LSN assessment of whole liver is time-consuming. Thus, it
is powerful for assessing LSN score from a single slice instead of whole liver
images. To our knowledge, no study has investigated one common measurement method
to assess LSN value from a single slice MR image, which would be an enormous
progress for the assessment of, for example, chronic hepatitis B and non-alcoholic
fatty liver disease (NAFLD).
Therefore, the purpose
of this study was to compare regional variation of LSN score for assessing
liver fibrosis on single axial liver MR images in chronic liver disease (CLD).Subjects and Methods
Overall, histopathologically proven 123 subjects
consisting of 111 CLD patients (mean age 41.8±11.2 years) and 12 normal controls (mean
age 35.5±13.8 years) were enrolled. All the subjects divided to four groups (F0-F3)
based on pathologic information: Group 1 (F0; normal control n=12), Group
2 (F1, n=9), Group 3 (F2, n=54), and Group 4 (F3,
n=47). MR images were obtained from 3-T liver axial MR imaging with three-dimensional
T1 high-resolution isotropic volume excitation (THRIVE) sequence. The
processing procedures for quantifying LSN are as follows: bias field correction,
semi-automatic liver boundary detection, liver segmentation; and LSN
measurements with multipolynomial curve fitting (Fig. 1). Mean LSN score
calculated as an averaged value measured from representative three slice images
(see Fig. 2). And, to measure regional LSN scores on a single axial MR image, five
different regions of interests (ROI1-5) were
analyzed to measure LSN score as shown in Fig. 2. LSN scores among
fibrosis grades in CLD were compared by using ANOVA with Tukey’s test. Weighting
value (Lwn) of LSN scores
in different ROIs was calculated as an averaged value derived from (Mean LSN / averaged
LSN score in ROIn) within each group.Results
Mean
LSN scores and regional LSN scores in each ROI were summarized in Table 1. Regional
LSN scores on ROI1-3
are not significant different whereas the scores on ROI4
and ROI5
and mean LSN score were significant difference between fibrosis groups (ANOVA;
ROI4 LSN p=0.006; ROI5
LSN p=0.004; mean LSN p<0.001, respectively). Figure 3
shows weighting values (Lwn) of each ROI derived from mean LSN score, and their Lwn values were listed in
Table 2. For LSN scores in a single axial MR image,
mean weighting values in ROIs were Lw1
0.864±0.048, Lw2 1.252±0.091, Lw3
0.972±0.038, Lw4 0.999±0.049 and Lw5
0.954±0.016, respectively. Especially, mean LSN scores showed
the strong correlation with regional ROI4 and ROI5
scores (inferior region in right lobe, r=0.376; r=0.524), giving significant difference within fibrosis grades (Table 3). Thus, the regional
LSN quantification can be a simple technique capable of detecting fibrotic
changes as a single measurement region, and moreover, our data focusing on
fibrosis grades of CLD can provide the evidence that LSN score is a useful
quantitative imaging biomarker that can be used to diagnose and stage hepatic
fibrosis.Conclusion
Regional LSN scores and their weighting values demonstrate
regional variations in the liver. These findings would provide useful
information for assessing the liver fibrosis. Moreover, the LSN scores in the inferior
region of right lobe (ROI4-5) would
be helpful for rapidly differentiating hepatic fibrosis in clinical practice as
a single measurement region.Acknowledgements
This study was supported by the grants of the
National Research Foundation of Korea (NRF) (2016M3A9A7918501) and the Korea Health
Technology R&D Project through the Korea Health Industry Development
Institute (KHIDI), funded by the Ministry of Health & Welfare (HI18C1216).References
- Smith, A. D. et al. Liver Surface
Nodularity Quantification from Routine CT Images as a Biomarker for Detection
and Evaluation of Cirrhosis. Radiology 2016; 280: 771-781.
- Pickhardt, P. J., Malecki, K., Kloke,
J. & Lubner, M. G. Accuracy of Liver Surface Nodularity Quantification on
MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis. AJR Am. J.
Roentgenol. 2016; 207: 1194-1199.
- Smith, A. D. et al. Liver Surface
Nodularity Score Allows Prediction of Cirrhosis Decompensation and Death.
Radiology 2017; 283: 711-722.
- Venkatesh, S. K. et al. Non-invasive
detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom.
Radiol. 2015; 40: 766-775.